Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss why higher rates pose the ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola ( NYSE: KO) and ...

Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.

Piper Sandler raised the firm’s price target on Arhaus (ARHS) to $15 from $14 and keeps an Overweight rating on the shares ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

We recently compiled a list of the 10 Buzzing AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report) today and set a price target of ...

Piper Sandler analyst Anna Andreeva upgraded Nike (NKE) to Overweight from Neutral with a price target of $90, up from $72. The firm says that ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Tuesday.

Piper Sandler Companies (NYSE:PIPR – Get Free Report) was downgraded by equities research analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report issued on ...